Intermittent Ephedrine Boluses for Prophylaxis Against Postinduction Hypotension
Condition(s) studied
Investigational drug(s) / intervention(s)
Normal Saline: four 10-mL syringes of normal saline, The patient will receive the first dose of the intervention with induction (0.1 ml/kg). After induction of anesthesia, the study drug will be given every 5 min for 20 min and will be withheld if MAP was ≥80 mmHg or if any vasopressor is given within 2 min of the current scheduled dose
Ephedrine: four 10-mL syringes of ephedrine 1 mg/mL. The patient will receive the first dose of the intervention with induction (0.1 ml/kg). After induction of anesthesia, the study drug will be given every 5 min for 20 min and will be withheld if MAP was ≥80 mmHg or if any vasopressor is given within 2 min of the current scheduled dose.
Study summary
The aim of this work is to assess the efficacy of intermittent ephedrine boluses in prophylaxis against postinduction hypotension in high-risk patients undergoing major abdominal surgery, compared to standard care.
Eligibility
Primary outcome measure(s)
- incidence of postinduction hypotension — from induction of anesthesia until 20 minutes after induction
mean arterial pressure \< 65 mmHg
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Kasr Alainy Hospital | Cairo | Egypt | Recruiting |
More Cairo University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07722013 on ClinicalTrials.gov ↗ ← All trials in Egypt